Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma
Clinical trial NCT05970666 · RECRUITING
Trial details
- NCT number
- NCT05970666
- Sponsor
- The First Affiliated Hospital of Xiamen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-15
- Primary completion
- 2026-11-15
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.